Lewy body/α-synucleinopathy in schizophrenia and depression: A preliminary neuropathological study

Acta Neuropathologica

Volumn 117, Issue 4, 2009, Pages 423-427

  Jellinger, Kurt A ^a  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

Synuclein; Bipolar disorder; Late life depression; Lewy pathology; Schizophrenia

Indexed keywords

ALPHA SYNUCLEIN;

AGED; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; LOCUS CERULEUS; MAJOR CLINICAL STUDY; MEYNERT BASAL NUCLEUS; PREVALENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCHIZOPHRENIA; SUBSTANTIA NIGRA; BRAIN; FEMALE; MAJOR DEPRESSION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; AUTOPSY; BIPOLAR DISORDER; BRAIN; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LEWY BODIES; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 62349133780     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-009-0492-5     Document Type: Article

References (39)

1. Al-Wandi A, Ninkina N, Millership S, Williamson SJ, Jones PA, Buchman VL (2008) Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice. Neurobiol Aging. Online 19 Dec 2008, doi: 10.1016/j.neurobiolaging.2008.1011.1001
2. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. Text revision, 4th edn. American Psychiatric Association, Washington, DC
3. Beach TG, Adler CH, Sue LI, Peirce JB, Bachalakuri J, Dalsing-Hernandez JE, Lue LF, Caviness JN, Connor DJ, Sabbagh MN, Walker DG (2008) Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol 115:445-451
4. Bennett MC (2005) The role of alpha-synuclein in neurodegenerative diseases. Pharmacol Ther 105:311-331
5. Bernstein HG, Krell D, Baumann B, Danos P, Falkai P, Diekmann S, Henning H, Bogerts B (1998) Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: Clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia. Schizophr Res 33:125-132
6. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389-404
7. Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 21:2042-2051
8. Dao-Castellana MH, Paillere-Martinot ML, Hantraye P, Attar-Levy D, Remy P, Crouzel C, Artiges E, Feline A, Syrota A, Martinot JL (1997) Presynaptic dopaminergic function in the striatum of schizophrenic patients. Schizophr Res 23:167-174
9. DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW (2008) Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 65:1074-1080
10. Dickson DW, Fujishiro H, DelleDonne A, Menke J, Zeshan A, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 115:437-444
11. Falkai P, Schneider-Axmann T, Honer WG (2000) Entorhinal cortex pre-alpha cell clusters in schizophrenia: Quantitative evidence of a developmental abnormality. Biol Psychiatry 47:937-943
12. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 114(Pt 5):2283-2301
13. Galvin JE (2006) Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: A case for the selective vulnerability of the substantia nigra. Acta Neuropathol 112:115-126
14. Gibb WR (1986) Idiopathic Parkinson's disease and the Lewy body disorders. Neuropathol Appl Neurobiol 12:223-234
15. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752
16. Haroutunian V, Religa D, Laudon H, Stycznska M, Winblad B, Naslund J (2003) Amyloid-beta pathology in Alzheimer's disease and schizophrenia. Online Abstract Viewer/Itinerary Planner Washington, DC. Society for Neuroscience, Program No. 447.442
17. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009) Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 66:13-20
18. Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65:303-326
19. Jeannotte AM, McCarthy JG, Redei EE, Sidhu A (2008) Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression. Neuropsychopharmacology. Online 17 Sept 2008, doi: 10.1038/npp.2008.1146
20. Jellinger KA, Gabriel E (1999) No increased incidence of Alzheimer's disease in elderly schizophrenics. Acta Neuropathol 97:165-169
21. Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111:1219-1235
22. Jellinger KA (2007) Morphological substrates of parkinsonism with and without dementia: A retrospective clinico-pathological study. J Neural Transm Suppl:91-104
23. Kazantsev AG, Kolchinsky AM (2008) Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease. Arch Neurol 65:1577-1581
24. Klos KJ, Ahlskog JE, Josephs KA, Apaydin H, Parisi JE, Boeve BF, DeLucia MW, Dickson DW (2006) Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology 66:1100-1102
25. Koziorowski D, Friedman A, Arosio P, Santambrogio P, Dziewulska D (2007) ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control. Parkinsonism Relat Disord 13:214-218
26. Lopez OL, Becker JT, Sweet RA, Martin-Sanchez FJ, Hamilton RL (2006) Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease. Neurology 67:660-665
27. Mirra SS, Gearing M, McKeel DW Jr, Crain BJ, Hughes JP, van Belle G, Heyman A (1994) Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: A study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). J Neuropathol Exp Neurol 53:303-315
28. Niizato K, Arai T, Kuroki N, Kase K, Iritani S, Ikeda K (1998) Autopsy study of Alzheimer's disease brain pathology in schizophrenia. Schizophr Res 31:177-184
29. Nikolaus S, Antke C, Kley K, Poeppel TD, Hautzel H, Schmidt D, Muller HW (2007) Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans. Rev Neurosci 18:439-472
30. Norris EH, Giasson BI, Lee VM (2004) Alpha-synuclein: Normal function and role in neurodegenerative diseases. Curr Top Dev Biol 60:17-54
31. Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, Iwatsubo T, Mizuno Y, Mochizuki H (2008) Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies. Exp Neurol 210:409-420
32. Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM, McCrystal J, Losonczy M, Davis KL (1993) Severe cognitive impairment in elderly schizophrenic patients: A clinicopathological study. Biol Psychiatry 33:255-260
33. Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, Gorman JM, Haroutunian V (2006) Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry 63:161-167
34. Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, White LR (2004) Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol 56:532-539
35. Scarr E, Gray L, Keriakous D, Robinson PJ, Dean B (2006) Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder. Bipolar Disord 8:133-143
36. Siever LJ, Davis KL (2004) The pathophysiology of schizophrenia disorders: Perspectives from the spectrum. Am J Psychiatry 161:398-413
37. Singleton AB (2005) Altered alpha-synuclein homeostasis causing Parkinson's disease: The potential roles of dardarin. Trends Neurosci 28:416-421
38. Sweet RA, Hamilton RL, Butters MA, Mulsant BH, Pollock BG, Lewis DA, Lopez OL, DeKosky ST, Reynolds CFIII (2004) Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology 29:2242-2250
39. World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. WHO, Geneva